Pembrolizumab in Early-Stage Non-Small Cell Lung Cancer After Complete Resection
ES/ONCO/1118/ ppt download
PEARLS/KENOTE-091】 完全切除後のぺムブロリズマブは有意に無病生存期間を延長 - キュート先生の『肺癌勉強会』
KEYNOTE-091 - Adjuvant Therapy for Stage 1B (T2a ≥4 cm), Stage 2, or Stage 3A NSCLC Clinical Trial Results
Treatment benefits and outcome determinants in (neo)adjuvant trials - memoinOncology
医药魔方
2022ESMO精彩研究抢先看（附摘要下载） - 知乎
20190511 rev Zürich Early stage NSCLC, SCLC and Mesothelioma
ES/ONCO/1118/0300. - ppt download
Stephen V Liu, MD on Twitter: "The #ESMOVirtualPlenary presented by Dr. @LuisPaz_Ares presents results from EORTC-1416-LCG / ETOP 8-15 / PEARLS / KEYNOTE-091: adjuvant pembrolizumab versus placebo for resected early stage #NSCLC. @
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial - The Lancet Oncology
Lancet Oncol：派姆单抗辅助治疗可显著延长术后IB-IIIA期NSCLC患者的生存期-MedSci.cn
Podcast Mary O'Brien, MD @drMaryOBr @royalmarsdenNHS #ASCO22 #OncoTwitter Phase III PEARLS/KEYNOTE-091 Discussion
Frühes nichtkleinzelliges Bronchialkarzinom: Pembrolizumab adjuvant nach Resektion verlängert das krankheitsfreie Überleben
Erfolg mit Pembrolizumab als Adjuvans bei reseziertem NSCLC | springermedizin.de
KEYTRUDA® (pembrolizumab) Showed Statistically Significant Improvement In Disease-Free Survival Versus Placebo As Adjuvant Treatment For Patients With Stage IB-IIIA Non-Small Cell Lung Cancer Regardless Of PD-L1 Expression 2023 - EORTC
Subgroup analysis of PEARLS/KEYNOTE-091: PD-L1 expression and outcomes of pembrolizumab - YouTube
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial | AIOM
Mary O'Brien, MD @drMaryOBr @royalmarsdenNHS #ASCO22 #OncoTwitter Phase III PEARLS/KEYNOTE-091 Discussion
关于KeyNote-091研究的几点思考及疑惑|人群|患者|研究|错误|阴性|-健康界
KEYNOTE-091 and IMPOWER010: adjuvant chemotherapy for NSCLC - YouTube
